Breaking News Instant updates and real-time market news.

2020-05-28 16:09:37 ADVM Adverum Biotechnologies $20.46 / -0.58 (-2.76%) 16:09 05/28/20 05/28 16:09 05/28/20 16:09	Adverum Biotechnologies reports Q1 EPS (31c), consensus (27c) Cash, cash equivalents and short-term investments were $297.1M as of March 31, compared to $166M as of December 31, 2019. In February, Adverum raised approximately $140.9M in net proceeds from an underwritten public offering. Adverum expects this quarter-end cash position to fund operations into 2022. "I'm thankful for the strong commitment and resilience our employees have exhibited towards advancing our pipeline despite the challenges of COVID 19," said Leone Patterson, president and CEO, Adverum Biotechnologies. "We continue to execute on our goal to develop and commercialize our novel gene therapy candidate ADVM-022 as a potential one-time treatment for patients with wet age-related macular degeneration (AMD) and DME, the two largest indications for anti-VEGF treatment. With the recent approval of our Investigational New Drug application for ADVM-022, we have initiated INFINITY in DME, a high-need subgroup of patients within the larger DR population. Additionally, we look forward to presenting data from all four cohorts of the OPTIC Phase 1 trial for ADVM-022 in wet AMD by the end of this year."	28 May 23 Jun
ADVM Adverum Biotechnologies $20.46 / -0.58 (-2.76%) 05/12/20 RBC Capital Adverum Biotechnologies initiated with an Outperform at RBC Capital 05/05/20 Truist Adverum Biotechnologies upgraded to Buy from Hold at SunTrust 05/05/20 Truist Adverum Biotechnologies upgraded to Buy from Hold at SunTrust 04/28/20 Goldman Sachs Adverum Biotechnologies initiated with a Buy at Goldman Sachs

2020-05-28 16:09:37

ADVM

Adverum Biotechnologies

$20.46 / -0.58 (-2.76%)

16:09

05/28/20

05/28

16:09

05/28/20

16:09

Adverum Biotechnologies reports Q1 EPS (31c), consensus (27c)

Cash, cash equivalents and short-term investments were $297.1M as of March 31, compared to $166M as of December 31, 2019. In February, Adverum raised approximately $140.9M in net proceeds from an underwritten public offering. Adverum expects this quarter-end cash position to fund operations into 2022. "I'm thankful for the strong commitment and resilience our employees have exhibited towards advancing our pipeline despite the challenges of COVID 19," said Leone Patterson, president and CEO, Adverum Biotechnologies. "We continue to execute on our goal to develop and commercialize our novel gene therapy candidate ADVM-022 as a potential one-time treatment for patients with wet age-related macular degeneration (AMD) and DME, the two largest indications for anti-VEGF treatment. With the recent approval of our Investigational New Drug application for ADVM-022, we have initiated INFINITY in DME, a high-need subgroup of patients within the larger DR population. Additionally, we look forward to presenting data from all four cohorts of the OPTIC Phase 1 trial for ADVM-022 in wet AMD by the end of this year."

28
May
23
Jun

ADVM Adverum Biotechnologies

$20.46 / -0.58 (-2.76%)

05/12/20 RBC Capital: Adverum Biotechnologies initiated with an Outperform at RBC Capital

05/05/20 Truist: Adverum Biotechnologies upgraded to Buy from Hold at SunTrust

05/05/20 Truist: Adverum Biotechnologies upgraded to Buy from Hold at SunTrust

04/28/20 Goldman Sachs: Adverum Biotechnologies initiated with a Buy at Goldman Sachs

TODAY'S FREE FLY STORIES

Syndicate	Phio Pharmaceuticals announces $14M private placement priced at-the-market » 15:35 01/21/21 01/21 15:35 01/21/21 15:35 PHIO Phio Pharmaceuticals $3.07 / + (+0.00%) Phio Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PHIO Phio Pharmaceuticals $3.07 / + (+0.00%) 08/05/20 Fly Intel: Top five analyst initiations 08/05/20 H.C. Wainwright Phio Pharmaceuticals initiated with a Buy at H.C. Wainwright
Periodicals	Judge sides with Amazon in Parler web-hosting case, NPR says » 15:34 01/21/21 01/21 15:34 01/21/21 15:34 AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) U.S. District Judge… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 01/19/21 Amazon invests in five new facilities in Quebec, creates over 1,000 new jobs 01/15/21 FCA announced as first OEM to implement Amazon's new Alexa Custom Assistant 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Lion Electric CEO: We are not an overnight success AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 08:39 Today BofA Amazon.com price target raised to $4,000 from $3,650 at BofA 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/11/21 Baird Baird remains a buyer of Amazon ahead of Q4 results 12/22/20 Wells Fargo Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 01/14/21 Fly Intel: What to watch in first round of big bank earnings reports 10/29/20 Amazon.com sees Q4 revenue $112B-$121B, consensus $112.32B 10/29/20 Amazon.com reports Q3 EPS $12.37, consensus $7.41 07/30/20 Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 15:04 Today Parler loses request for injunction against Amazon, Bloomberg reports 01/20/21 Amazon's Twitch 'indefinitely' suspends Donald Trump, Verge says 01/20/21 Amazon says 'ready to assist' with COVID vaccination efforts, GeekWire reports 01/20/21 Amazon sues EU regulators for allowing Italian case to proceed, Reuters says AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 02/02/21 Amazon.com - AMZN AMZN Amazon.com $3,316.24 / +49.1 (+1.50%) 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th 08/18/20 Early notable gainers among liquid option names on August 18th
Options	Seagate options imply 7.9% move in share price post-earnings » 15:34 01/21/21 01/21 15:34 01/21/21 15:34 STX Seagate $62.26 / +0.83 (+1.35%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options STX Seagate $62.26 / +0.83 (+1.35%) 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products 11/05/20 Climb Channel Solutions adds Seagate data storage systems to distribution line STX Seagate $62.26 / +0.83 (+1.35%) 07:08 Today Barclays Seagate price target raised to $60 from $41 at Barclays 01/20/21 Wedbush Seagate price target raised to $56 from $47 at Wedbush 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland 01/19/21 Loop Capital Seagate price target raised to $70 from $60 at Loop Capital STX Seagate $62.26 / +0.83 (+1.35%) 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c 10/22/20 Notable companies reporting after market close 10/22/20 Fly Intel: What to watch in data storage earnings reports STX Seagate $62.26 / +0.83 (+1.35%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/23/20 Fly Intel: Pre-market Movers 16:30 Today Seagate - STX STX Seagate $62.26 / +0.83 (+1.35%) 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish 10/22/20 Seagate put volume heavy and directionally bearish
Options	Ambarella call volume above normal and directionally bullish » 15:25 01/21/21 01/21 15:25 01/21/21 15:25 AMBA Ambarella $110.03 / +4.97 (+4.73%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AMBA Ambarella $110.03 / +4.97 (+4.73%) 01/11/21 Ambarella unveils CV5 AI vision processor with 8K capabilities 12/28/20 FAA adopts final rules for drones 'advancing opportunities' for utilization 12/02/20 AWS partnering with Nvidia and Ambarella to enable AWS Panorama Device SDK 12/01/20 Ambarella CTO sells 20K shares of common stock AMBA Ambarella $110.03 / +4.97 (+4.73%) 07:47 Today Stifel Ambarella price target raised to $118 from $110 at Stifel 01/13/21 Roth Capital Ambarella upgraded to Buy with $130 price target at Roth Capital 01/13/21 Roth Capital Ambarella upgraded to Buy from Neutral at Roth Capital 01/05/21 Craig-Hallum Ambarella price target raised to $115 from $90 at Craig-Hallum AMBA Ambarella $110.03 / +4.97 (+4.73%) 11/24/20 Ambarella sees Q4 revenue $56M-$60M, consensus $52.31M 11/23/20 Ambarella reports Q3 EPS 9c, consensus 5c 09/02/20 Ambarella sees Q3 revenue $52M-$56M, consensus $55.12M 09/02/20 Ambarella reports Q2 EPS 6c, consensus (2c) AMBA Ambarella $110.03 / +4.97 (+4.73%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 12/07/20 Fly Insider: Foot Locker, Alexion among weeks notable insider trades 11/23/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference AMBA Ambarella $110.03 / +4.97 (+4.73%) 12/10/20 Ambarella call volume above normal and directionally bullish 12/03/20 Ambarella call volume above normal and directionally bullish 11/23/20 Ambarella options imply 12.9% move in share price post-earnings 09/01/20 Ambarella call volume above normal and directionally bullish
Conference/Events	Jefferies auto/auto parts analyst to hold an analyst/industry conference call » 15:25 01/21/21 01/21 15:25 01/21/21 15:25 Auto & Auto Parts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Periodicals	Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports » 15:21 01/21/21 01/21 15:21 01/21/21 15:21 PFE Pfizer $36.45 / -0.035 (-0.10%) , BNTX BioNTech $107.01 / +3.71 (+3.59%) Pfizer (PFE) has cut in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 07:09 Today Cerevel Therapeutics appoints Deval Patrick, Deborah Baron to board 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus 01/14/21 Pfizer says FDA approves supplemental NDA for Xalkori 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 BNTX BioNTech $107.01 / +3.71 (+3.59%) 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus 01/12/21 Canada orders 20M more doses of Pfizer, BioNTech Covid vaccine 01/08/21 Pfizer, BioNTech COVID vaccine elicits antibodies that neutralize mutation 01/07/21 BioNTech reports publication of preclinical data on novel mRNA vaccine approach PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg BNTX BioNTech $107.01 / +3.71 (+3.59%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 BNTX BioNTech $107.01 / +3.71 (+3.59%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate 23 Jul 06 Feb PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 14:52 Today Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Japan inks deal with Pfizer for COVID vaccine for 72M people, Nikkei reports 01/20/21 Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports BNTX BioNTech $107.01 / +3.71 (+3.59%) 14:52 Today Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports 01/04/21 Pfizer, BioNTech offered South Africa discounted vaccines, Bloomberg says PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $107.01 / +3.71 (+3.59%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 01/24/21 PDUFA Date for Xalkori (Crizotinib) - January 2021 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE BNTX PFE Pfizer $36.45 / -0.035 (-0.10%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th BNTX BioNTech $107.01 / +3.71 (+3.59%) 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th 11/02/20 Largest borrow rate increases among liquid names
Periodicals	Biden poised to freeze oil, coal leasing on federal land, Bloomberg says » 15:20 01/21/21 01/21 15:20 01/21/21 15:20 ACI Albertsons $17.43 / +0.12 (+0.69%) , ANR Alpha Natural $0.00 / + (+0.00%) , ARLP Alliance Resource Partners $5.26 / -0.25 (-4.54%) , CNX CNX Resources $12.32 / -0.13 (-1.04%) , BTU Peabody Energy $3.48 / -0.495 (-12.47%) , CLDP Cloud Peak Energy $0.00 / + (+0.00%) President Joe Biden is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ACI ANR ARLP CNX BTU ACI Albertsons $17.43 / +0.12 (+0.69%) 11/30/20 Albertsons associates ratify agreement with UFCW local unions 11/24/20 Albertsons implements contactless temperature, health screening 11/19/20 Albertsons incorporates SNAP EBT payments at Drive Up & Go locations 11/12/20 Albertsons to partner with HHS to provide COVID-19 vaccine ANR Alpha Natural $0.00 / + (+0.00%) 07/27/20 Deutsche Bank seeks to exit global business activities in coal mining by 2025 ARLP Alliance Resource Partners $5.26 / -0.25 (-4.54%) 07/27/20 Deutsche Bank seeks to exit global business activities in coal mining by 2025 CNX CNX Resources $12.32 / -0.13 (-1.04%) 11/16/20 Einhorn's Greenlight buys Twitter, exits Whirlpool in Q3 10/22/20 CNX Resources rises after Bloomberg reports on EQT takeover interest 10/22/20 CNX Resources jumps 16% to $11.99 after Bloomberg report of EQT bid 09/28/20 CNX Resources, CNX Midstream Partners announce completion of merger BTU Peabody Energy $3.48 / -0.495 (-12.47%) 12:00 Today Peabody Energy falls -11.8% 10:00 Today Peabody Energy falls -7.9% 01/06/21 Peabody Energy falls -6.6% 01/05/21 Peabody Energy rises 13.8% ACI ANR ARLP CNX BTU CLDP ACI Albertsons $17.43 / +0.12 (+0.69%) 01/20/21 Morgan Stanley Albertsons downgraded to Underweight with $13 price target at Morgan Stanley 01/20/21 Morgan Stanley Kroger downgraded to Underweight at Morgan Stanley 01/20/21 Morgan Stanley Albertsons downgraded to Underweight from Equal Weight at Morgan Stanley 01/15/21 Tigress Financial Tigress continues to recommend Albertsons purchases, sees further upside ANR Alpha Natural $0.00 / + (+0.00%) ARLP Alliance Resource Partners $5.26 / -0.25 (-4.54%) 02/04/20 Benchmark Benchmark starts 'under-owned and shunned' Alliance Resource Partners at Buy 02/04/20 Benchmark Alliance Resource Partners initiated with a Buy at Benchmark CNX CNX Resources $12.32 / -0.13 (-1.04%) 01/15/21 JPMorgan CNX Resources initiated with an Overweight at JPMorgan 12/15/20 BofA CNX Resources initiated with a Neutral at BofA 12/15/20 BofA CNX Resources initiated with a Neutral at BofA 10/30/20 MKM Partners CNX Resources upgraded to Buy from Neutral at MKM Partners BTU Peabody Energy $3.48 / -0.495 (-12.47%) 08/07/20 Vertical Research Peabody Energy downgraded to Hold from Buy at Vertical Research 05/07/20 Clarksons Platou Peabody Energy downgraded to Neutral from Buy at Clarksons Platou 03/20/20 Deutsche Bank Peabody Energy downgraded to Hold from Buy at Deutsche Bank 02/10/20 Benchmark Benchmark starts Arch Coal at Buy, sees opportunity after selloff CLDP Cloud Peak Energy $0.00 / + (+0.00%) ACI CNX BTU ACI Albertsons $17.43 / +0.12 (+0.69%) 01/12/21 Albertsons raises FY20 adjusted EPS view to $3.05-$3.15 from $2.75-$2.85 01/12/21 Albertsons reports Q3 adjusted EPS 66c, consensus 42c 01/11/21 Notable companies reporting before tomorrow's open 01/11/21 Notable companies reporting before tomorrow's open CNX CNX Resources $12.32 / -0.13 (-1.04%) 07/30/20 CNX Resources reports Q2 EPS (78c), consensus 2c BTU Peabody Energy $3.48 / -0.495 (-12.47%) 11/09/20 Peabody Energy reports Q3 cont ops EPS 66c, consensus 92c 08/05/20 Peabody Energy reports Q2 EPS ($15.76), consensus ($1.28) 26 Jun ACI CNX ACI Albertsons $17.43 / +0.12 (+0.69%) 09/19/20 Albertsons a Buy as stock looks cheap, Barron's says CNX CNX Resources $12.32 / -0.13 (-1.04%) 10/22/20 EQT pursuing acquisition of CNX Resources, Bloomberg reports 10/22/20 EQT recently made takeover proposal to CNX Resources, Bloomberg says 10/22/20 EQT said to pursue acquisition of CNX Resources, Bloomberg reports ACI CNX ACI Albertsons $17.43 / +0.12 (+0.69%) 01/12/21 Fly Intel: Pre-market Movers 11/09/20 Fly Intel: What to watch in Beyond Meat earnings report 10/20/20 Fly Intel: Pre-market Movers 10/14/20 Fly Intel: After-Hours Movers CNX CNX Resources $12.32 / -0.13 (-1.04%) 10/23/20 Fly Intel: Pre-market Movers 10/22/20 Fly Intel: Wall Street's top stories for Thursday 07/27/20 Fly Intel: Wall Street's top stories for July 27 07/27/20 Fly Intel: Wall Street's top stories at midday 01/28/21 CNX Resources - CNX 02/01/21 Alliance Resource Partners - ARLP ACI BTU ACI Albertsons $17.43 / +0.12 (+0.69%) 01/13/21 Largest borrow rate increases among liquid names 01/12/21 Largest borrow rate increases among liquid names 01/11/21 Largest borrow rate increases among liquid names 01/07/21 Largest borrow rate increases among liquid names BTU Peabody Energy $3.48 / -0.495 (-12.47%) 12/29/20 Unusual call flow in option market yesterday 08/11/20 Largest borrow rate increases among liquid names
Options	CSX options imply 4.6% move in share price post-earnings » 15:19 01/21/21 01/21 15:19 01/21/21 15:19 CSX CSX $91.77 / -1.45 (-1.56%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CSX CSX $91.77 / -1.45 (-1.56%) 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 CSX CSX $91.77 / -1.45 (-1.56%) 01/20/21 Susquehanna Railroad recovery expected to continue in 2021, says Susquehanna 01/11/21 Citi CSX price target raised to $105 from $87 at Citi 12/10/20 Morgan Stanley Morgan Stanley downgrades CSX to Underweight with bar raised too high 12/10/20 Morgan Stanley CSX downgraded to Underweight from Equal Weight at Morgan Stanley CSX CSX $91.77 / -1.45 (-1.56%) 14:41 Today Notable companies reporting after market close 10/21/20 CSX reports Q3 EPS 96c, consensus 92c 10/21/20 Notable companies reporting after market close 07/22/20 CSX reports Q2 EPS 65c, consensus 64c CSX CSX $91.77 / -1.45 (-1.56%) 10/21/20 Fly Intel: After-Hours Movers 16:30 Today CSX - CSX CSX CSX $91.77 / -1.45 (-1.56%) 10/22/20 Early notable gainers among liquid option names on October 22nd 09/15/20 CSX call volume above normal and directionally bullish 09/04/20 CSX put volume heavy and directionally bearish 07/31/20 CSX call volume above normal and directionally bullish
Technical Analysis	NASDAQ market internals summary » 15:17 01/21/21 01/21 15:17 01/21/21 15:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 15:16 01/21/21 01/21 15:16 01/21/21 15:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary

Hot Stocks	Momentus announces service agreement with Qosmosys » 15:14 01/21/21 01/21 15:14 01/21/21 15:14 SRAC Stable Road Acquisition $23.70 / -0.56 (-2.31%) Momentus and Qosmosys… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals Options SRAC Stable Road Acquisition $23.70 / -0.56 (-2.31%) 01/04/21 Momentus to delay its January launch further into 2021 10/07/20 Momentus to become public through merger with Stable Road Acquisition SRAC Stable Road Acquisition $23.70 / -0.56 (-2.31%) 10/06/20 Stable Road in talks to bring Momentus public via merger, Bloomberg says 10/06/20 Momentus in talks to go public via Stable Road Acquisition deal, Bloomberg says SRAC Stable Road Acquisition $23.70 / -0.56 (-2.31%) 01/04/21 Largest borrow rate increases among liquid names 12/31/20 Largest borrow rate increases among liquid names 12/16/20 Stable Road Acquisition Corporation put volume heavy and directionally bearish 12/02/20 Largest borrow rate increases among liquid names
Recommendations	Unibail-Rodamco-Westfield price target lowered to EUR 45 at Barclays » 15:13 01/21/21 01/21 15:13 01/21/21 15:13 UNBLF Unibail-Rodamco-Westfield $0.00 / + (+0.00%) Barclays analyst Sander… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research UNBLF Unibail-Rodamco-Westfield $0.00 / + (+0.00%) 12/10/20 Goldman Sachs Unibail-Rodamco-Westfield upgraded to Buy from Neutral at Goldman Sachs 12/07/20 Deutsche Bank Unibail-Rodamco-Westfield price target lowered to EUR 70 at Deutsche Bank 11/24/20 Goldman Sachs Unibail-Rodamco-Westfield upgraded to Neutral from Sell at Goldman Sachs 11/23/20 JPMorgan Unibail-Rodamco-Westfield resumed with an Underweight at JPMorgan
Recommendations	Svenska Handelsbanken price target raised to SEK 105 from SEK 102 at Barclays » 15:11 01/21/21 01/21 15:11 01/21/21 15:11 SVNLY Svenska Handelsbanken $0.00 / + (+0.00%) Barclays analyst Namita… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SVNLY Svenska Handelsbanken $0.00 / + (+0.00%) 01/14/21 SEB Equities Svenska Handelsbanken upgraded to Hold from Sell at SEB Equities 01/11/21 UBS Svenska Handelsbanken price target raised to SEK 89 from SEK 82 at UBS 12/09/20 Deutsche Bank Svenska Handelsbanken price target raised to SEK 112 at Deutsche Bank 12/01/20 JPMorgan Svenska Handelsbanken price target lowered to SEK 70 from SEK 75 at JPMorgan
Recommendations	Smith & Nephew price target lowered to 1,875 GBp from 1,900 GBp at Barclays » 15:10 01/21/21 01/21 15:10 01/21/21 15:10 SNN Smith & Nephew $44.83 / -1.04 (-2.27%) Barclays analyst Hassan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SNN Smith & Nephew $44.83 / -1.04 (-2.27%) 01/04/21 Integra LifeSciences completes sale of Extremity Orthopedics unit to Smith & Nephew 11/20/20 Smith & Nephew notes that FY20 guidance remains withdrawn 09/29/20 Integra to divest Extremity Orthopedics business to Smith & Nephew for $240M SNN Smith & Nephew $44.83 / -1.04 (-2.27%) 13:47 Today Berenberg Smith & Nephew price target raised to 2,005 GBp from 1,975 GBp at Berenberg 01/20/21 Berenberg Smith & Nephew price target raised to 2,005 GBp from 1,975 GBp at Berenberg 12/18/20 JPMorgan Smith & Nephew price target lowered to 1,438 GBp from 1,596 GBp at JPMorgan 12/18/20 Bernstein Smith & Nephew upgraded to Outperform from Market Perform at Bernstein
Recommendations	Pearson price target raised to 630 GBp from 520 GBp at Barclays » 15:10 01/21/21 01/21 15:10 01/21/21 15:10 PSO Pearson $9.81 / -0.23 (-2.29%) Barclays analyst Nick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PSO Pearson $9.81 / -0.23 (-2.29%) 12/02/20 Pearson announces Mike Howells as new Chief Strategy Officer 10/14/20 Pearson 'on track' to deliver 2020 outturn in line with expectations 08/24/20 Pearson names Disney executive Andy Bird as new CEO, effective October 19 PSO Pearson $9.81 / -0.23 (-2.29%) 05:14 Today Exane BNP Paribas Pearson downgraded to Neutral from Outperform at Exane BNP Paribas 01/12/21 Berenberg Pearson price target raised to 475 GBp from 450 GBp at Berenberg 12/17/20 UBS Pearson price target raised to 750 GBp from 650 GBp at UBS 12/09/20 Fly Intel: Top five analyst downgrades PSO Pearson $9.81 / -0.23 (-2.29%) 10/14/20 Pearson reports Q3 revenue down 10% y/y vs. down 28% in Q2 07/24/20 Pearson reports 1H EPS 6.3p versus 6.1p in 1H19

Recommendations	Nordea Bank price target raised to SEK 7.60 from SEK 7.40 at Barclays » 15:09 01/21/21 01/21 15:09 01/21/21 15:09 NRDBY Nordea Bank $0.00 / + (+0.00%) Barclays analyst Namita… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals Events NRDBY Nordea Bank $0.00 / + (+0.00%) 12/09/20 Deutsche Bank Nordea Bank upgraded to Buy from Hold at Deutsche Bank 12/01/20 JPMorgan Nordea Bank price target raised to SEK 75 from SEK 70 at JPMorgan 11/30/20 Barclays Nordea Bank price target raised to EUR 7.40 from EUR 7.30 at Barclays 11/20/20 JPMorgan Nordea Bank price target raised to SEK 70 from SEK 65 at JPMorgan NRDBY Nordea Bank $0.00 / + (+0.00%) 08/31/20 Activists caution Samsung C&T over Vietnam coal project, Bloomberg reports 02/04/21 Nordea Bank - NRDBY
Hot Stocks	Old Point Financial announces Q4 pre-tax expenses of $1M » 15:06 01/21/21 01/21 15:06 01/21/21 15:06 OPOF Old Point Financial $20.75 / +0.75 (+3.75%) Old Point Financial plans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	IMI PLC price target raised to 1,465 GBp from 1,230 GBp at Barclays » 15:06 01/21/21 01/21 15:06 01/21/21 15:06 IMIAY IMI PLC $0.00 / + (+0.00%) Barclays analyst Jonathan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research IMIAY IMI PLC $0.00 / + (+0.00%) 01/18/21 Goldman Sachs IMI PLC upgraded to Conviction Buy from Buy at Goldman Sachs 01/15/21 Morgan Stanley IMI PLC price target raised to 1,400 GBp from 1,320 GBp at Morgan Stanley 01/13/21 Credit Suisse IMI PLC upgraded to Outperform at Credit Suisse on guidance upside 01/13/21 Credit Suisse IMI PLC upgraded to Outperform from Neutral at Credit Suisse
Periodicals	Parler loses request for injunction against Amazon, Bloomberg reports » 15:04 01/21/21 01/21 15:04 01/21/21 15:04 AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) Previously it was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 01/19/21 Amazon invests in five new facilities in Quebec, creates over 1,000 new jobs 01/15/21 FCA announced as first OEM to implement Amazon's new Alexa Custom Assistant 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Lion Electric CEO: We are not an overnight success AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 08:39 Today BofA Amazon.com price target raised to $4,000 from $3,650 at BofA 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/11/21 Baird Baird remains a buyer of Amazon ahead of Q4 results 12/22/20 Wells Fargo Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 01/14/21 Fly Intel: What to watch in first round of big bank earnings reports 10/29/20 Amazon.com sees Q4 revenue $112B-$121B, consensus $112.32B 10/29/20 Amazon.com reports Q3 EPS $12.37, consensus $7.41 07/30/20 Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 01/20/21 Amazon's Twitch 'indefinitely' suspends Donald Trump, Verge says 01/20/21 Amazon says 'ready to assist' with COVID vaccination efforts, GeekWire reports 01/20/21 Amazon sues EU regulators for allowing Italian case to proceed, Reuters says 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 02/02/21 Amazon.com - AMZN AMZN Amazon.com $3,319.68 / +52.54 (+1.61%) 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th 08/18/20 Early notable gainers among liquid option names on August 18th
Options	IBM options imply 6.3% move in share price post-earnings » 15:04 01/21/21 01/21 15:04 01/21/21 15:04 IBM IBM $132.01 / +1.93 (+1.48%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IBM IBM $132.01 / +1.93 (+1.48%) 01/19/21 IBM, Atos expand strategic global alliance for digital transformation 01/14/21 IBM to acquire Taos, terms not disclosed 01/14/21 Vonage names Jay Bellissimo as COO 01/11/21 IBM acquires 7Summits, terms not disclosed IBM IBM $132.01 / +1.93 (+1.48%) 10/20/20 Morgan Stanley Morgan Stanley continues to view IBM as 'a 2022 stock' 10/20/20 Citi IBM is 'getting even more complex,' says Citi 10/20/20 BMO Capital IBM price target lowered to $138 from $140 at BMO Capital 10/09/20 Morgan Stanley IBM price target raised to $140 from $128 at Morgan Stanley IBM IBM $132.01 / +1.93 (+1.48%) 14:41 Today Notable companies reporting after market close 10/19/20 IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7% 10/19/20 IBM reports Q3 adjusted EPS $2.58, consensus $2.58 10/19/20 Notable companies reporting after market close IBM IBM $132.01 / +1.93 (+1.48%) 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/06/21 IBM restructuring sales organization, WSJ reports 11/25/20 IBM to eliminate 10,000 positions in Europe ahead of unit sale, Bloomberg says 10/11/20 IBM split might not mean speedy recovery, WSJ says IBM IBM $132.01 / +1.93 (+1.48%) 12:29 Today Fly Intel: What to watch in IBM's earnings report 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 17:00 Today IBM - IBM IBM IBM $132.01 / +1.93 (+1.48%) 01/05/21 Unusually active option classes on open January 5th 10/30/20 IBM call volume above normal and directionally bullish 10/19/20 IBM options imply 6.1% move in share price post-earnings 10/08/20 Early notable gainers among liquid option names on October 8th

Recommendations	DNB ASA price target raised to NOK 131 from NOK 120 at Barclays » 15:03 01/21/21 01/21 15:03 01/21/21 15:03 DNHBY DNB ASA $0.00 / + (+0.00%) Barclays analyst Namita… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DNHBY DNB ASA $0.00 / + (+0.00%) 01/11/21 Berenberg DNB ASA price target raised to NOK 180 from NOK 150 at Berenberg 01/11/21 UBS DNB ASA downgraded to Sell from Neutral at UBS 12/09/20 Deutsche Bank DNB ASA price target raised to NOK 180 from NOK 151 at Deutsche Bank 12/01/20 JPMorgan DNB ASA price target raised to NOK 180 from NOK 165 at JPMorgan
Recommendations	Danske Bank price target raised to DKK 105 from DKK 104 at Barclays » 15:02 01/21/21 01/21 15:02 01/21/21 15:02 DNKEY Danske Bank $0.00 / + (+0.00%) Barclays analyst Namita… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DNKEY Danske Bank $0.00 / + (+0.00%) 01/11/21 UBS Danske Bank price target raised to DKK 138 from DKK 130 at UBS 12/09/20 Deutsche Bank Danske Bank price target raised to DKK 115 from DKK 104 at Deutsche Bank 12/01/20 JPMorgan Danske Bank price target lowered to DKK 95 from DKK 98 at JPMorgan 11/24/20 Morgan Stanley Danske Bank downgraded to Underweight from Equal Weight at Morgan Stanley
Recommendations	BASF price target raised to EUR 64 from EUR 60 at Barclays » 15:01 01/21/21 01/21 15:01 01/21/21 15:01 BASFY BASF $0.00 / + (+0.00%) Barclays analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals Events BASFY BASF $0.00 / + (+0.00%) 13:32 Today Deutsche Bank BASF price target raised to EUR 86 from EUR 71 at Deutsche Bank 01/15/21 Berenberg BASF price target raised to EUR 74 from EUR 52 at Berenberg 01/12/21 Bernstein BASF upgraded to Outperform from Market Perform at Bernstein 01/11/21 JPMorgan BASF downgraded to Underweight from Neutral at JPMorgan BASFY BASF $0.00 / + (+0.00%) 07/29/20 Bayer sends PI to U.S. farm in bid to overturn weedkiller decision, Reuters says 02/26/21 BASF - BASFY
Periodicals	CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says » 15:01 01/21/21 01/21 15:01 01/21/21 15:01 CSGP CoStar Group $902.59 / +1.59 (+0.18%) , CLGX CoreLogic $77.33 / +1.625 (+2.15%) CoStar Group (CSGP) and a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 12/29/20 Apartments.com Network acheives 1B website visits in 2020 12/18/20 CoStar Group acquires Houses.com 12/17/20 CoStar Group receives FTC clearance to close acquisition of Homesnap 11/30/20 FTC sues to block CoStar Group's proposed acquisition of RentPath CLGX CoreLogic $77.33 / +1.625 (+2.15%) 12/11/20 CoreLogic expects final bids for company in early 2021 11/24/20 CoreLogic board 'fully supportive' of 'robust' sale process 11/23/20 Cannae, Senator ask CoreLogic to set board vote record date 11/17/20 CoreLogic shareholders elect Senator, Cannae nominees to board CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 12/22/20 JMP Securities RealPage price target raised to $101 from $80 at JMP Securities 11/23/20 Wells Fargo CoStar Group price target raised to $990 from $915 at Wells Fargo 10/28/20 Truist CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist 10/28/20 Needham CoStar Group price target raised to $1,000 from $825 at Needham CLGX CoreLogic $77.33 / +1.625 (+2.15%) 01/06/21 Wolfe Research CoreLogic downgraded to Underperform from Peer Perform at Wolfe Research 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist 10/28/20 Truist CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 10/27/20 CoStar Group sees FY20 EPS $9.39-$9.49, consensus $9.36 10/27/20 CoStar Group sees Q4 EPS $2.34-$2.44, consensus $2.51 10/27/20 CoStar Group reports Q3 EPS $2.26, consensus $2.07 07/28/20 CoStar Group sees FY20 adjusted EPS $9.22-$9.42, consensus $9.11 CLGX CoreLogic $77.33 / +1.625 (+2.15%) 12/11/20 CoreLogic raises FY21 adjusted EPS view to $4.40-$4.65 from $4.00-$4.20 12/11/20 CoreLogic raises FY20 adjusted EPS view to $4.15-$4.25 from $3.65 10/22/20 CoreLogic sees FY20 results at upper end of guidance range 10/22/20 CoreLogic reports Q3 EPS $1.21, consensus $1.24 21 May CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 14:43 Today CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says 12/29/20 Rentpath terminates deal to be acquired by CoStar Group, Bloomberg says 11/22/20 CoStar in advanced talks to acquire Homesnap for $250M, WSJ reports 10/28/20 CoreLogic receiving buyout interest above $80 per share, CNBC reports CLGX CoreLogic $77.33 / +1.625 (+2.15%) 14:43 Today CoStar, Warburg group final bidders in running for CoreLogic, Bloomberg says 12/01/20 CoreLogic interest seen being 'strong,' CTFN reports 12/01/20 CTFN publishes report on CoreLogic auction plans 11/17/20 CoreLogic investors likely to win three board seats, Bloomberg reports CSGP CLGX CSGP CoStar Group $902.59 / +1.59 (+0.18%) 10/28/20 Fly Intel: Wall Street's top stories for Wednesday 10/28/20 Fly Intel: Wall Street's top stories at midday CLGX CoreLogic $77.33 / +1.625 (+2.15%) 10/28/20 Fly Intel: Wall Street's top stories for Wednesday 10/28/20 Fly Intel: Wall Street's top stories at midday
Recommendations	Aveva price target raised to 3,730 GBp from 3,560 GBp at Barclays » 15:00 01/21/21 01/21 15:00 01/21/21 15:00 AVEVF Aveva $0.00 / + (+0.00%) Barclays analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events AVEVF Aveva $0.00 / + (+0.00%) 08/25/20 Aveva to acquire OSIsoft for $5B AVEVF Aveva $0.00 / + (+0.00%) 01/20/21 Berenberg Aveva upgraded to Buy from Hold at Berenberg 01/05/21 UBS Aveva upgraded to Buy from Neutral at UBS 01/04/21 Investec Aveva upgraded to Buy from Hold at Investec 12/11/20 Credit Suisse Aveva price target lowered to 3,620 GBp from 4,690 GBp at Credit Suisse 02/11/21 Technology & Internet Virtual Conference

Events

Earnings calls, analyst events, roadshows and more

Today at 16:00

Autos & Auto Parts Industry Meetings
KRBP
Today at 16:15

Kiromic BioPharma - KRBP Conference Calls
STX
Today at 16:30

Seagate - STX Conference Calls
IDXG
Today at 16:30

Interpace Biosciences - IDXG Conference Calls
TENX
Today at 16:30

Tenax Therapeutics - TENX Conference Calls
ISRG
Today at 16:30

Intuitive Surgical - ISRG Conference Calls
CSX
Today at 16:30

CSX - CSX Conference Calls
PBCT
Today at 17:00

People's United - PBCT Conference Calls
ASB
Today at 17:00

Associated Banc-Corp - ASB Conference Calls
TCBI
Today at 17:00

Texas Capital - TCBI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Adverum Biotechnologies reports Q1 EPS (31c), consensus (27c)

TODAY'S FREE FLY STORIES

Get Full Fly Access